Clin2
NCT07187817Possibly a fitRecruiting

Sequential biologic treatments for psoriasis

Psoriasis

Part of Skin clinical trials.

This trial looks at how different biologic treatments work when used one after another for people with plaque psoriasis. It may help find the best order of treatments to keep your skin clear.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
366 people
Ages
18 years and older
Study type
Observational

Who can take part

  • You have been diagnosed with chronic plaque psoriasis by a skin doctor.
  • You have received between 1 and 10 previous biologic or targeted synthetic treatments for psoriasis in the UK.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05111210Recruiting
IL-23/IL-17 psoriasis treatment study to understand skin immune changes

This study looks at what’s happening inside the body in people with plaque psoriasis who start certain biologic medicines that target the IL-23/IL-17 immune pathway. It may help explain why these treatments work and what body changes are linked to response.

Paris, Île-de-France Region
NCT01706692Recruiting
Study registry for targeted treatments in psoriasis patients

This trial is a registry that collects information from adults with plaque psoriasis or psoriatic arthritis who are starting a new biologic or other systemic treatment. It helps researchers understand how these treatments are used in real life and what outcomes they may have.

Aarau
NCT06477237Recruiting· Phase 3
Testing a new psoriasis shot for moderate to severe plaque

This trial tests a new medication called HB0017 for moderate to severe plaque psoriasis. It aims to see if it is safe and effective in reducing skin symptoms and improving quality of life.

Jiangmen, Guangdong
NCT07204639Recruiting· Phase 2
Testing CBP-0276 for moderate to severe psoriasis

This trial tests a new medication, CBP-0276, to see if it improves psoriasis symptoms and quality of life. It is for people with moderate to severe plaque psoriasis who might need stronger treatment.

Mexico City
NCT04119102Recruiting· Phase 4
Duobrii added to biologic treatment for plaque psoriasis

This trial tests whether adding Duobrii (a prescription psoriasis lotion) on top of your current biologic treatment helps improve plaque psoriasis. It includes adults whose psoriasis is in a moderate range and who have already been on a biologic for at least 24 weeks.

East Windsor, New Jersey
NCT05270733Recruiting· Phase 4
Predicting psoriasis response using advanced skin-cell testing

This study looks at skin cells at the single-cell level to predict which psoriasis treatments will work best for you. It may help doctors personalize treatment choices for plaque psoriasis.

Cleveland, Ohio

Hear when a new Psoriasis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.